[Drug committees are not necessary--therapeutic recommendations are issued anyway].
Jönsson
Bengt
B
Centrum för hälsoekonomi, Handelshögskolan i Stockholm. Beng.Jonsson@hhs.se
D003362:Cost-Benefit Analysis; D016527:Drug Costs; D004346:Drug Information Services; D006801:Humans; D010606:Pharmacy and Therapeutics Committee; D017410:Practice Guidelines as Topic; D013548:Sweden